MEDVi vs Willow

Both sell tirzepatide. MEDVi costs $399 a month and Willow costs $399. The desk reads it as follows.

MEDVi is tablet and injection choice. Willow is straightforward single-price plans. They are not aimed at the same person, and the cheaper one is not automatically the right answer — though on this board it usually is.

Advert against bill. MEDVi advertises $399 and bills $399; Willow advertises $399 and bills $399. Both gaps are the same size, so the advertised comparison happens to hold.

Side by side

Prices verified 2026-09-18. "True monthly cost" is what you are billed in month two, once any introductory rate has lapsed and any membership has renewed.

The split

They differ on 1 of the 7 things we track, and behave the same on the other 6. The differences are what the price gap is actually buying.

What each puts on the record: MEDVi

• Compounded tirzepatide injections listed at $399/month.
• Tirzepatide tablet pricing is quoted after the intake questionnaire rather than published up front.

Where it wins: Injection pricing is consistent between the first month and renewals. Watch for: You have to complete intake before seeing tablet pricing. Injection pricing is published at $399.

What each puts on the record: Willow

• Compounded tirzepatide listed at $399/month.

Where it wins: A single price with no membership arithmetic. Watch for: There is little published detail on how dose changes are handled. Ask before committing.

In each one’s favour

MEDVi.

• Injection pricing is consistent between the first month and renewals.
• Tablet option for people who will not inject.

Willow.

• A single price with no membership arithmetic.

How they score

Willow scores higher overall at 2.9 out of 5. The weights are published on how we rate, and so is the note about which of these is our paid featured partner.

The desk’s call

• Pick MEDVi if cost is the binding constraint. Over a year the gap is about $0, which is real money for the same class of medication.
• Pick Willow if what it does better matters to you — a single price with no membership arithmetic.
• Ask both which pharmacy compounds the medication and whether it is a 503A or 503B facility. Neither publishes it.

The verdict

On the board, MEDVi at $399 a month is the more defensible choice on arithmetic alone. Willow earns its premium only if you will actually use what it does differently. Read the full reviews before deciding: MEDVi and Willow.

How they sit against everyone else